Bayer’s Pipeline Refresh Focuses On Early Stage Despite Near-Term Growth Needs

Interview With Pharma R&D Head Christian Rommel

 
• By Mandy Jackson
Christian Rommel
Scrip spoke with Bayer's Christian Rommel during the J.P. Morgan meeting • Source: Bayer

More from Business

More from Scrip